Haupt Pharma AG, a leading contract development and manufacturing organisation (CDMO), is headquartered in Berlin, Germany, with significant operations across Europe and beyond. Founded in 1994, the company has established itself in the pharmaceutical industry, specialising in the development and production of solid dosage forms, sterile products, and complex formulations. Haupt Pharma's core offerings include a diverse range of pharmaceutical products and services, distinguished by their commitment to quality and innovation. The company has achieved notable milestones, including the expansion of its manufacturing capabilities and the establishment of strategic partnerships within the industry. With a strong market position, Haupt Pharma AG is recognised for its expertise in providing tailored solutions that meet the evolving needs of its clients, ensuring compliance with stringent regulatory standards.
How does Haupt Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Haupt Pharma AG's score of 10 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Haupt Pharma AG currently does not have publicly available carbon emissions data for recent years, as no specific figures have been reported. Additionally, there are no documented reduction targets or initiatives outlined in their climate commitments. This absence of data suggests that the company may still be in the early stages of formalising its climate strategy or reporting on its carbon footprint. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon emissions. While Haupt Pharma AG has not yet disclosed specific targets or achievements, it is essential for organisations in this sector to develop comprehensive strategies to mitigate their environmental impact. This includes setting measurable goals for reducing Scope 1, 2, and 3 emissions, which encompass direct emissions from owned or controlled sources, indirect emissions from the generation of purchased energy, and other indirect emissions in the value chain. As the industry moves towards greater transparency and accountability in climate action, it will be crucial for Haupt Pharma AG to establish and communicate its commitments to sustainability and carbon reduction in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haupt Pharma AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.